Cargando…
DEPDC1B collaborates with GABRD to regulate ESCC progression
BACKGROUND: Esophageal squamous cell carcinoma (ESCC) is the leading cause of cancer-related death worldwide with a poor prognosis. Given that DEPDC1B plays a key role in multiple cancers, the role of this molecule in ESCC was explored to identify potential targets for ESCC patients. METHOD: The exp...
Autores principales: | Yuan, Yunfeng, Ping, Wei, Zhang, Ruijie, Hao, Zhipeng, Zhang, Ni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202211/ https://www.ncbi.nlm.nih.gov/pubmed/35706026 http://dx.doi.org/10.1186/s12935-022-02593-z |
Ejemplares similares
-
Knockdown of DEPDC1B inhibits the development of glioblastoma
por: Chen, Xu, et al.
Publicado: (2020) -
GABRD promotes progression and predicts poor prognosis in colorectal cancer
por: Niu, Gengming, et al.
Publicado: (2020) -
miR-378d suppresses malignant phenotype of ESCC cells through AKT signaling
por: Peng, Jie, et al.
Publicado: (2021) -
Overexpressed DEPDC1B contributes to the progression of hepatocellular carcinoma by CDK1
por: Dang, Xiao-Wei, et al.
Publicado: (2021) -
Gamma-Aminobutyric Acid Type A Receptor Subunit Delta (GABRD) Inhibits Breast Cancer Progression by Regulating the Cell Cycle
por: Wu, Liang, et al.
Publicado: (2023)